Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Hyperfine, Inc. - Class A Common Stock
(NQ:
HYPR
)
1.010
-0.010 (-0.98%)
Streaming Delayed Price
Updated: 1:20 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hyperfine, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
Next >
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024
March 07, 2024
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference
February 28, 2024
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes
February 21, 2024
From
Hyperfine, Inc.
Via
Business Wire
Recap: Hyperfine Q3 Earnings
November 09, 2023
Via
Benzinga
Recap: Hyperfine Q1 Earnings
May 11, 2023
Via
Benzinga
Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study
February 01, 2024
From
Hyperfine, Inc.
Via
Business Wire
Why VCI Global Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket
January 12, 2024
Shares of VCI Global Limited (NASDAQ: VCIG) fell sharply in pre-market trading after the company announced pricing of $2.75 million public offering. VCI Global shares tumbled 29.5% to $1.10 in...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 12, 2024
We're starting out the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use
January 09, 2024
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023
November 20, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference
November 16, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Hyperfine, Inc.
Via
GlobeNewswire
Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients
November 02, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. to Announce Third Quarter Financial Results on November 9, 2023
October 19, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs Executives
October 10, 2023
From
Hyperfine, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
October 09, 2023
Via
Benzinga
Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences
October 09, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. to Present at Gilmartin Group Emerging Growth Showcase
September 07, 2023
From
Hyperfine, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 06, 2023
Via
Benzinga
Hyperfine, Inc. Reports Second Quarter 2023 Financial Results
August 14, 2023
From
Hyperfine, Inc.
Via
GlobeNewswire
Enrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Inc. Portable MR Imaging® System
August 09, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. to Announce Second Quarter Financial Results on August 14, 2023
July 24, 2023
From
Hyperfine, Inc.
Via
Business Wire
Earnings Scheduled For August 14, 2023
August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via
Benzinga
Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating Officer
July 18, 2023
From
Hyperfine, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 18, 2023
Via
Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 18, 2023
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 18, 2023
Via
Benzinga
Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care
July 11, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. and the International Society for Magnetic Resonance in Medicine Collaborate to Enhance Global Access to MR Education
June 08, 2023
From
Hyperfine, Inc.
Via
Business Wire
Hyperfine, Inc. Receives Grant for an Additional Three Years to Utilize Innovative Swoop® Portable MR Imaging® System in Low and Middle-Income Countries
May 18, 2023
From
Hyperfine, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.